Possibility of hepatic resection in patients on maintenance hemodialysis.
A review of seven hepatic resections in six patients undergoing maintenance hemodialysis is presented. These cases consisted of hepatocellular carcinoma in four, and cholangiocellular carcinoma, myelolipoma and focal nodular hyperplasia in one each. The last preoperative hemodialysis was undertaken within 24 h prior to the operation with heparin. Intraoperatively, infused solutions containing no potassium, along with strict attention to preventing overhydration, allowed us to manage the patients without hemodialysis on the day of the operation. No specific intra-operative complications related to hemodialysis were noted. Postoperative hemodialysis was performed on the first or second day after operation, using nafamstat mesilate, a synthetic protease-inhibiting agent. The morbidity rate in the hemodialyzed patients was 85.7% (6/7), which was significantly higher than that in the non-hemodialyzed patients who underwent hepatic resections in our hospital. Fluid collection in the pleural and/or peritoneal cavities was frequent and difficult to control, but transient. Our experience suggests that hepatic resection is an acceptable procedure for hemodialyzed patients, when used in conjunction with careful perioperative management.
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
M
M
Yamagata
T
T
Kanematsu
T
T
Matsumata
T
T
Nishizaki
T
T
Utsunomiya
K
K
Sugimachi
S
S
Okuda
D002759:Adenoma, Bile Duct / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D000328:Adult; D001650:Bile Duct Neoplasms / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D005706:Gallbladder Neoplasms / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D006391:Hemangioma / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D007677:Kidney Function Tests; D008067:Lipoma / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D008113:Liver Neoplasms / Q000401:mortality / Q000503:physiopathology / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011137:Polystyrenes / Q000008:administration & dosage; D011183:Postoperative Complications / Q000401:mortality / Q000503:physiopathology; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis; D015996:Survival Rate; D014882:Water-Electrolyte Balance / Q000502:physiology
D011137:Polystyrenes; C003321:polystyrene sulfonic acid; D011188:Potassium